 | 2/4/2008 - An expert panel working with the FDA recently voted 10 to 2 against approving Merck's statin drug Mevacor for over-the-counter (OTC) sales. The FDA could potentially ignore this recent vote and approve Merck's request but this is not a likely scenario considering the results of a recent Merck sponsored...
|